Florham Park Medical + Durham Life Sciences (Diversified III)
Legal trust name JLLX Diversified III, DST
Talk to a 1031 specialistData updated May 7, 2024
Offering size$95.9M
Asset typeHealthcare
LocationMulti-state
FinancingNot disclosed
Regulation D exemptionRule 506(b)
Sponsor-reported potential 721/UPREIT exitNo
First filedNov 8, 2023
Last filedMay 7, 2024
Minimum$75k
DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current Private Placement Memorandum before investing.
Still operating, no exit yet
JLLX Diversified III, DST was fully subscribed at $95 million in June 2024 (Florham Park outpatient medical + Durham life sciences); no full-cycle or UPREIT announcement has appeared as of July 2026, and SEC EDGAR Form D filings show only routine amendments, indicating the trust is still holding its properties through the required holding period [5][6].
Supporting evidence
First filedNov 8, 2023
Latest filingMay 7, 2024
Filings tracked12
View filing on SEC EDGARForm D is an issuer notice filing. A filing does not mean the SEC approved, endorsed, or verified the offering.
In the news
Frequently asked questions
Is Florham Park Medical + Durham Life Sciences (Diversified III) currently active?
Florham Park Medical + Durham Life Sciences (Diversified III) is part of the researched historical archive. “Active” reflects the latest public record and does not confirm that interests remain available.
Where does Top1031 get the data for Florham Park Medical + Durham Life Sciences (Diversified III)?
Top1031 tracks this offering from SEC Form D filings and cited sponsor disclosures. Filing data may lag current subscriptions and does not mean the SEC approved or verified the offering.